LOC730183: A Potential Drug Target and Biomarker (G730183)

Target Name: LOC730183

NCBI ID: G730183

LOC730183

Other Name(s): uncharacterized LOC730183 | Uncharacterized LOC730183, transcript variant 2

LOC730183: A Potential Drug Target and Biomarker

LOC730183 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its unique expression pattern and subcellular localization in the tissues make it an attractive candidate for drug targeting. Additionally, its presence in the protein-coding gene has led to its potential as a biomarker for various diseases.

The protein encoded by LOC730183 is a member of the LOC73018 family, which is characterized by the presence of a unique N-terminal domain called P2. P2 domains are known for their ability to interact with various molecules, including small molecules, peptides, and proteins. In the case of LOC730183, the P2 domain interacts with the protein target, which is not yet known.

LOC730183 is expressed in a variety of tissues and organs, including the brain, heart, and kidneys. In the brain, LOC730183 is found in the cerebral cortical layer, as well as in the cerebellum and entorhinal cortex. In the heart, it is expressed in the cardiac muscle and in the pericardium. In the kidneys, it is found in the brush border and in the interstitial cells.

The subcellular localization of LOC730183 within the various tissues and organs make it a potential drug target. The brain is home to many diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative disorders. The heart is also a common target for drugs used to treat hypertension, heart failure, and other cardiovascular diseases. The kidneys are also a target for many drugs used to treat chronic kidney disease.

In addition to its potential as a drug target, LOC730183 also has the potential as a biomarker for various diseases. The expression of LOC730183 has been observed in a variety of diseases, including neurodegenerative disorders, cardiovascular disease, and diabetes. Additionally, its expression has been correlated with the progression of certain diseases, such as cancer.

The identification of a potential drug target and biomarker for LOC730183 is an exciting development in the field of neuroscience and pharmacology. Further research is needed to determine the specific mechanism by which LOC730183 interacts with its protein targets and how it can be used as a biomarker for various diseases. However, the potential of LOC730183 as a drug target and biomarker is clear, and further studies are likely to shed light on its role in the development of new treatments for a variety of diseases.

Protein Name: Uncharacterized LOC730183

The "LOC730183 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC730183 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets